Kidney cancer trials in China

In China 117 Also abroad 486

117 trials · From ClinicalTrials.gov, checked 13 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
PET/CT-Directed Free of Therapy for Metastatic RCC Patients With IMDC Favorable or Intermediate Risk
Where
Nanjing
Age
18 years and over
People
30
Run by
Jinling Hospital, China
See details and how to joinNCT07175480
Phase 3Not yet taking people in China
A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI
Where
Beijing
Age
18 years to 80 years
People
116
Run by
Peking University Cancer Hospital & Institute
See details and how to joinNCT07165418
No phaseTaking people
Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT
Where
Beijing
Age
18 years to 85 years
People
1,000
Run by
Peking University First Hospital
See details and how to joinNCT07166445
No phaseTaking people
Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy
Where
Nanjing
Age
18 years to 80 years
People
190
Run by
Shao Pengfei
See details and how to joinNCT07141225
Phase 2Taking people
A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
Where
Nanjing
Age
18 years to 80 years
People
35
Run by
Jinling Hospital, China
See details and how to joinNCT06255223
Phase 2Taking people
Ivonescimab in the Treatment of Multiple Advanced Tumors
Where
Shanghai
Age
18 years and over
People
400
Run by
Fudan University
See details and how to joinNCT06683846
No phaseTaking people
Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment
Where
Wuhan
Age
18 years and over
People
400
Run by
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT07118813
Phase 2Enrolling by invitation
68Ga-NYM096 PET/ CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal Masses
Where
Beijing
Age
18 years and over
People
100
Run by
Peking Union Medical College Hospital
See details and how to joinNCT07101900
Phase 1/2Taking people
Study of HS-10516 Combination Therapy in Patients With Advanced Renal Cell Carcinoma
Where
Beijing
Age
18 years and over
People
104
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07097935
Early phase 1Taking people
Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
Where
Beijing
Age
18 years and over
People
15
Run by
Chinese PLA General Hospital
See details and how to joinNCT07067905
Phase 1/2Taking people
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Where
Beijing
Age
16 years to 85 years
People
90
Run by
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC
See details and how to joinNCT07053462
Phase 1/2Taking people
Clinical Safty and Efficacy Study of Infusion of iNKT Cells and CD8+T Cells in Patients With Advanced Solid Tumor
Where
Shanghai
Age
18 years to 70 years
People
40
Run by
Shanghai Public Health Clinical Center
See details and how to joinNCT03093688
No phaseTaking people
Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation Study
Where
Nanjing
Age
18 years to 80 years
People
232
Run by
Shao Pengfei
See details and how to joinNCT07020169
Phase 1Taking people
A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid Tumors
Where
Hangzhou
Age
18 years and over
People
30
Run by
Weijia Fang, MD
See details and how to joinNCT05518253
No phaseTaking people
Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)
Where
Chongqing
People
800
Run by
Mingzhao Xiao
See details and how to joinNCT06088134
No phaseTaking people
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
Where
Xiamen
Age
18 years to 74 years
People
113
Run by
The First Affiliated Hospital of Xiamen University
See details and how to joinNCT06956144
No phaseTaking people
Systemic Anti-tumor Activity and Safety of the Combination of SBRT and Concurrent PD-1 Blockade in Metastatic RCC.
Where
Guangzhou
Age
18 years and over
People
20
Run by
Nanfang Hospital, Southern Medical University
See details and how to joinNCT06327178
No phaseNot yet taking people in China
The Study on the Effectiveness of [68Ga]Ga-HBED-CC-DiAsp PET/CT in Calculating GFR and Predicting Residual Renal Function After Partial Nephrectomy
Where
Beijing
Age
18 years to 88 years
People
40
Run by
Luo Yaping
See details and how to joinNCT06973798
No phaseTaking people
The Value of a Convolutional Neural Network-Based Renal Artery Perfusion Model in Predicting Renal Function After Partial Nephrectomy: A Prospective Study
Where
Nanjing
Age
18 years to 80 years
People
300
Run by
Shao Pengfei
See details and how to joinNCT06751498
No phaseTaking people
Prospective Evaluation of Cornerstone Robotics Sentire Surgical System in Major Gastrointestinal and Urologic Surgery
Where
Hong Kong
Age
18 years to 80 years
People
90
Run by
Chinese University of Hong Kong
See details and how to joinNCT06926374
Phase 3Taking people
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
Where
Beijing, Shanghai
Age
18 years and over
People
413 worldwide
Run by
Xynomic Pharmaceuticals, Inc.
See details and how to joinNCT03592472
No phaseTaking people
Prospective Study on the Safety and Efficacy of Robot-Assisted Laparoscopic Partial Nephrectomy With Renal Artery Off-Clamp in the Treatment of cT1 Renal Tumors
Where
Nanjing
Age
18 years to 80 years
People
60
Run by
The First Affiliated Hospital with Nanjing Medical University
See details and how to joinNCT06908902
Phase 2Taking people
SABR Combined with Axitinib and Toripalimab in Recurrent or Metastatic RCC
Where
Beijing
Age
18 years to 80 years
People
30
Run by
Peking University First Hospital
See details and how to joinNCT06889649
No phaseTaking people
Optimising Renal Tumour Management Through Artificial Intelligence Modules
Where
Nanjing
Age
18 years and over
People
2,100
Run by
Shao Pengfei
See details and how to joinNCT06714916
No phaseNot yet taking people in China
Validation of the EQ-5D-Y-3L and EQ-5D-Y-5L for Paediatric Patients in China
Where
Guiyang
Age
5 years to 16 years
People
360
Run by
RenJi Hospital
See details and how to joinNCT06873672